Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma

In the Hong Kong two-round screening cohort, first-round EBV DNA fragmentomics plus quantity identified participants with an 87.1-fold higher relative risk of developing NPC at the second round, compared with PCR-negative participants.

Cancer CellPubMed 40054465DOI 10.1016/j.ccell.2025.02.002